U.S. Food Stock News

Science Applications International (SAIC) drew fresh attention after recent trading left the stock around $106.73, with mixed short term returns in contrast to gains over the past month and past three months. See our latest analysis for Science Applications International. Over a longer window, Science Applications International’s share price return has been steadier than the recent pullback, with the stock posting gains over the past month, quarter and year to date, while the 1 year total...

With the Federal Reserve holding rates at 3.5%–3.75% and signaling that borrowing costs may stay restrictive for longer, some financial stocks look more closely tied to this higher rate backdrop than others. This article uses a targeted screener to highlight three large banking and insurance stocks that appear especially exposed to the latest Fed news, whether through lending margins, underwriting income, or balance sheet positioning. You will see how each stock lines up against a higher for...

Recent trading in Delek US Holdings (DK) has drawn attention after the stock ended the latest session at $42.34, with moves over the past week and month showing declines alongside strong year to date and 1 year total returns. See our latest analysis for Delek US Holdings. The recent pullback, including a 3.88% one day share price decline and weaker 7 day and 30 day share price returns, contrasts with Delek US Holdings' much stronger 1 year and multi year total shareholder returns. This...

At the EAACI 2026 congress in Istanbul, Pharvaris reported Phase 3 RAPIDe-3 data showing rapid, sustained efficacy and favorable safety for its oral deucrictibant capsule in treating hereditary angioedema attacks, alongside supportive long-term prophylaxis and cardiovascular safety findings. A distinctive feature of the update was the introduction of the End of Progression™ endpoint, highlighting how quickly deucrictibant can halt worsening symptoms and potentially improve patients’...

In its latest reported quarter, Green Plains Inc. posted a 25.89% year-over-year revenue decline and a very large year-over-year drop in net profit, while still ranking 6th out of 29 peers for financial health in the Renewable Energy industry. This combination of weaker quarterly performance and relatively strong balance sheet positioning creates a mixed picture that may influence how investors weigh Green Plains' transition plans and risk profile. Now we’ll consider how this steep quarterly...

Hut 8 (HUT) is drawing fresh attention after a series of AI focused moves, including large investment grade project financing, long term data center leases, and the appointment of E. Stanley O’Neal as board chair. See our latest analysis for Hut 8. Against that backdrop of board changes, large bond financing and long term AI data center leases, Hut 8’s 1 day share price return declined 2.14% to $118.88. Its 90 day share price return of 137.10% and very large 1 year total shareholder return...

Recently, Bio-Rad Laboratories reported year-over-year growth in both revenue and net profit while institutional investors, led by First Eagle Investment, significantly reduced their holdings and technical indicators leaned toward selling. This contrast between strengthening financial results and declining institutional ownership, alongside neutral-to-weak technical signals, raises fresh questions about how different investor groups are interpreting Bio-Rad’s underlying business...

In recent days, Axcelis Technologies was caught in a broader pullback across semiconductor equipment makers, as concerns about chip capital spending and macroeconomic headwinds triggered a sector-wide selloff. Investor caution has been reinforced by views that the shares trade above intrinsic value and by recent insider stock sales totaling US$5.9 million over three months. We’ll now examine how this sector-wide risk-off sentiment, combined with valuation concerns, may influence Axcelis...

CEVA (CEVA) is back in focus after Needham and other firms highlighted its role in Physical AI, following first quarter 2026 earnings that surpassed analyst expectations on the strength of licensing revenue. See our latest analysis for CEVA. CEVA’s share price has climbed sharply in recent months, with a 30 day share price return of 22.74% and a 90 day share price return of 136.74%. The 1 year total shareholder return of 118.01% points to strong momentum building around its Physical AI and...

Recent analyst reports on Xenia Hotels & Resorts (XHR) are drawing attention to an earnings outlook described as favorable and broadly positive ratings, alongside technical indicators that currently lean bullish for the stock. See our latest analysis for Xenia Hotels & Resorts. The recent move in Xenia Hotels & Resorts' share price to $19.53 sits against a strong run, with a 30 day share price return of 19.3% and a year to date share price return of 36.19%, while total shareholder return over...

Bandwidth (BAND) has drawn fresh attention after recent trading left the stock down around 14% over the past week and about 9% over the past month, despite strong multi year total returns. See our latest analysis for Bandwidth. The recent pullback leaves Bandwidth’s share price at US$50.84, with the 7 day share price return down 14.28% and the 30 day share price return down 9.13%. However, the 90 day share price return of about 23x suggests momentum has been very strong over the medium term...

Tanger (SKT) continues to attract attention as a retail focused REIT, with recent returns over the past month and past 3 months prompting investors to reassess how the stock fits into income oriented portfolios. See our latest analysis for Tanger. The latest 1 day share price decline of 4.19% to US$38.68 comes after a stronger 30 day share price return of 8.50% and a 1 year total shareholder return of 34.21%, suggesting recent momentum has cooled slightly while longer term returns remain...

Karman Holdings (KRMN) stock moved after the company’s audit committee replaced Baker Tilly with PricewaterhouseCoopers as independent auditor for 2026, following earlier disclosures about material weaknesses in internal control over financial reporting. See our latest analysis for Karman Holdings. Karman Holdings stock has shown mixed momentum, with a 7 day share price return of 13.43% and a 1 year total shareholder return of 13.11%, but a 90 day share price decline of 50.89% and a year to...

The Federal Reserve’s decision to hold rates at 3.50%-3.75% while hinting at a possible hike later in 2026 has sharpened the focus on financial stocks that can either handle, or potentially benefit from, higher borrowing costs and stickier inflation. With Treasury yields moving higher and the outlook for cheaper mortgages fading, investors are reconsidering where bank and insurance stocks might fit in a portfolio. This article highlights 3 large, established Financials from the screener that...

SpaceX’s record-breaking US$75b IPO and rapid move to acquire AI startup Cursor have pushed trading volumes and speculation to intense levels, and that activity can ripple directly into market infrastructure and trading platform stocks. This article looks at how that news might affect three companies from a Market Infrastructure & Trading Platforms screener, each tied in different ways to trading activity, liquidity and investor sentiment. It outlines which stocks appear to be positioned to...

IPG Photonics recently presented at the EPHJ trade show in Geneva, Switzerland, while competitor Laser Photonics announced its entry into the data center laser market and secured an order for a robotic laser cleaning cell linked to data center supply chains. This combination of IPG’s outreach to advanced manufacturing customers and a rival’s push into a key data center opportunity highlights shifting competitive dynamics in one of IPG’s targeted growth areas. Next, we’ll examine how Laser...

Recent bullish coverage from firms such as Canaccord Genuity, highlighting Twist Bioscience (TWST) silicon-based lab-on-a-chip platform and AI-enabled drug discovery efforts, has pushed Twist Bioscience stock firmly into focus for many investors. See our latest analysis for Twist Bioscience. That bullish research comes after a sharp move in the Twist Bioscience share price. The stock closed at US$82.87, with a 30 day share price return of 66.44% and a 1 year total shareholder return of...

Capri Holdings (CPRI) stock has been drawing attention after recent price moves, with the shares closing at $19.73. Investors are reassessing the global luxury group’s current valuation and earnings profile. See our latest analysis for Capri Holdings. The recent pullback to a 1 day share price return of down 4.96% comes after a stronger run, with a 30 day share price return of 12.49% and a 1 year total shareholder return of 15.45%. At the same time, longer term total shareholder returns over...

PTC Therapeutics (PTCT) has drawn fresh attention after launching a $500 million private placement of 0% convertible senior notes due 2031, aimed at refinancing existing 2026 convertible debt and supporting general corporate needs. See our latest analysis for PTC Therapeutics. PTC Therapeutics shares have been volatile around the $78.53 level, with a 1-day share price return of 7.18% and a 90-day share price return of 17.08%, while the 1-year total shareholder return of 55.72% points to...

The market in the United States has shown positive momentum, with a 2.0% increase over the last week and a notable 23% rise over the past year, while earnings are anticipated to grow by 19% annually in the coming years. In such an environment, identifying stocks that are trading below their intrinsic value can offer potential opportunities for investors looking to capitalize on undervalued assets amidst overall market growth.

The United States market has experienced a positive trajectory, with a 2.0% increase over the last week and a significant 23% rise in the past year, while earnings are projected to grow by 19% annually. In such an environment, stocks that not only demonstrate growth potential but also have high insider ownership can be particularly appealing as they suggest strong confidence from those closest to the company’s operations and future prospects.

The market has climbed 2.0% in the last 7 days and has seen a remarkable 23% increase over the past year, with earnings expected to grow by 19% annually. While penny stocks may seem like a term from another era, they still offer intriguing opportunities for investors seeking growth at accessible price points. By focusing on companies with strong financials and solid fundamentals, these stocks can present hidden value without many of the typical risks associated with this segment of the market.

Hilton Grand Vacations (HGV) is back in focus after completing a $300 million securitization of timeshare loans, a funding move paired with recent equity activity and a planned $40 million share repurchase. See our latest analysis for Hilton Grand Vacations. Hilton Grand Vacations’ recent securitization and buyback announcement come against a strong backdrop, with a 30 day share price return of 11.7% and a 1 year total shareholder return of 32.27%, suggesting momentum has been building rather...

Tariffs of 10% to 12.5% proposed on almost all imported goods have pushed customs brokerage and trade compliance stocks into the spotlight, as companies reassess how they move products across borders and protect margins. For investors, this screen of U.S. Customs Brokerage and Trade Compliance Services stocks is a way to see which businesses could gain from higher demand for compliance support as rules become more complex. This article highlights 3 stocks exposed to this tariff story that are...